Phytopharm Share Discussion Threads

[mrsapeslaptop] 28/7/2011 17:11

that is brilliant news.
orphan drug status for ALS.

If we get positive in vivo news on ALS in Q4. should treble share price at least on the potential for a licence

[madmonkflin] 20/7/2011 15:26

always a bloody drop off at the end of the day...

[mrsapeslaptop] 20/7/2011 15:13

cheers tp. been sitting and adding for 2 years though. and hasn't broken out yet. still can wait another 18 months

[tpaulbeaumont] 20/7/2011 10:46

nice andy :)

[madmonkflin] 20/7/2011 10:37

ok, not far away. Would be interested to know if the Chinese have been doing any trials.

[engelo] 20/7/2011 10:33

madmonk: 2010's interim management statement was 18th August.

[engelo] 20/7/2011 10:17

mrsA: well done here! Have been keeping an eye open from your quiet hints on the SUMM thread.

Thought it would wait: wrong again!!

[mrsapeslaptop] 20/7/2011 09:28

dont know. we still don't know who bought the 4m shares in June. and why that didnt move the price then. I think its a potential partner stakebuilding. even though results arent due for a while, they must be having conversations/ drawing up the shortlist of partners. hey ho.

[madmonkflin] 20/7/2011 08:21

and lot of movement of not very much volume. when's next quarterly update due?

[mrsapeslaptop] 19/7/2011 15:45

link to the ALS research

[mrsapeslaptop] 19/7/2011 15:23

since I mostly mutter to myself on here.

If the ALS study is positive
We could do a licence on that for P2 onwards.
and use the proceeds t0 fund a P3 on Parkinsons. that would be quite cool (to me).

[mrsapeslaptop] 19/7/2011 15:10

well. we should get an ALS update this yesr. and if positive "move rapidly into clinical trials". which would be P2.

The ALS market is potentially $2Bn- $4Bn p.a.

no really effective treatements.

and the potential for orphan drug classification by the FDA



onwards and upwards

[7bore] 19/7/2011 15:00

The Scotsman
19 Jul 2011


One to watch: Phytopharm

Published Date: 19 July 2011

Phytopharm is a development-stage pharmaceutical company. The group's lead series of compounds, the Sapogenins, has the potential to be a new class of therapy for neuro-degenerative diseases, including Parkinson's, motor neuron and glaucoma.
Phytopharm's origins were focussed on attempts to develop products extracted from botanical sources based on Chinese remedies. This has now developed into the synthetic manufacturing of Cogane and Myogane, the former a potential treatment for Parkinson's and motor neuron, the latter a treatment for glaucoma.

By its own admission, Phytopharm is a high-risk prospect. However, the trials for both Cogane and Myogane have proved encouraging. The group has received a grant of $1.16 million (£7520,000) from the Michael J Fox Foundation and, following an equity issue in 2009, has sufficient cash to fund a development programme until the trials are concluded.

For those looking for a classic high-risk "high-reward" investment in a developing pharmaceutical company, Phytopharm could be interesting.

Phytopharm
7.8p +0.05p
Scotsman says BUY

[7bore] 19/7/2011 14:57

MrsApeslaptop - 19 Jul'11 - 15:38 - 44 of 45
"tipped in the scotsman apparently. so that will be another 20 pence flooding in :)"


lol !

20p...what makes you think every single Scot in Scotland read todays paper?

[7bore] 19/7/2011 14:55

MrsApeslaptop

thx for the update. will add to my watchlist...again.

[mrsapeslaptop] 19/7/2011 14:38

couldnt find a reason for today's rise

tipped in the scotsman apparently. so that will be another 20 pence flooding in :)

[7bore] 19/7/2011 14:19

just browsing.

its been over 8 years since i was last in these when their anti obesity drug failed trials.

anything happened since then :0)

[mrsapeslaptop] 12/7/2011 18:15

so we are expecting news on glaucoma in Q4. i.e. can we move rapidly into phase 2 trials.

an idea of licence sizes going into P2 in glaucoma



up to $20m worldwide rights. $170m total deal.

should underwrite the value of the company a bit if possitive

[madmonkflin] 29/6/2011 10:08

that was a brave buy(or sell) of 192 shares.

[mrsapeslaptop] 23/6/2011 23:00

I'm disappointed with the lack of PI interest. but aftera all its gone from 600p to 6p. but IMHO prospects are actually better than ever before.
I had thought of this bcompnayeing 50p ish. but if it works in multiple indications then could be a £1bn + company (500p ish). oh well. thats the joy of being a contrarian investor

[baldeagle5] 23/6/2011 19:26

Another lumpy purchase today... someones accumulating.

[mrsapeslaptop] 22/6/2011 22:36

this may be premature as the merkets are a cruel mistress..

but watch and learn. I think we are off to the races

[mrsapeslaptop] 22/6/2011 15:52

4th highest daily volume in 10 years, and didnt move